| Name | Title | Contact Details |
|---|
Turn 14 Distribution is a Performance Warehouse Distributor with distribution facilities strategically located in Hatfield, PA, Arlington, TX, Reno, NV, and Indianapolis, IN. Turn 14 Distributions strategy consists of catering to niche vehicle markets, along with stocking its partner manufacturers full product lines for quick order fulfillment. Exclusive Turn 14 Distribution promotions ensure that products are marketed efficiently and correctly to each suppliers target audience. The company relies upon its dedicated sales specialists—chosen for their experience in each particular market—to service its customers with superior knowledge. In addition, the companys website offers lens technology to permit customers to view the products available for each individual market most efficiently. Turn 14 Distributions up-to-the-minute online inventory tracking, efficient forecasting, and dedicated Customer Support Department allow the company to cut lead times and keep its customers informed about product fulfillment. The companys goal is to provide its customers the sales, marketing, and post-sales support needed to succeed in the modern marketplace. With 1,500,000 sq ft of modern distribution center space, Turn 14 Distribution boasts ground shipping coverage to 60% of the U.S. population in one day and 100% within two days. Globally, Turn 14 Distributions competitive freight rates, ship to your shop flat rate shipping, late shipping cutoff times, seven-day-a-week operation, and same day in-stock order fulfillment commitment enable it to service customers both across the United States and the world efficiently.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
LEAD3R is not your typical executive search firm; we help you create a winning formula that unlocks potential at every level of your leadership team, through recruitment, coaching, and advisory services. We are your strategic partner in ensuring your organization flourishes at every level, driving long-term success through the ever-evolving business environment.
Elementary is a company specializing in advanced machine vision inspection, utilizing AI and automation to enhance manufacturing processes. Founded in mid-2017 by experienced professionals from various sectors, the company aims to develop a new generation of manufacturing products that rely on computer vision and AI. Their platform automates traceability scans and integrates AI, machine vision, and automation into production lines. This approach focuses on improving quality, traceability, and root cause analyses, making manufacturing processes more efficient. Elementary emphasizes a human-in-the-loop strategy, enhancing collaboration between humans and machines to optimize working conditions and outcomes. Based in Los Angeles, California, Elementarys team includes roboticists, computer scientists, designers, and engineers. The company has attracted significant funding, including a $30 million Series B round led by Tiger Global, to support its innovative solutions in manufacturing. Their technology is utilized by notable clients across various industries, including Toyota in the automotive sector.